We are revolutionizing the translational potential of animal models in preclinical research. Discover the latest articles and news about our recent activities.
12 May 2025
PhoenixBio is excited to be sponsoring a booth and attending the American Society for Gene & Cell Therapy (ASGCT 2025) in person in New Orleans, USA from May 13th - 17th, 2025. Meet with our team at Booth #1444 to learn more about PhoenixBio's capabilities and how we can help you improve lives through safe and effective cell and gene therapies.
7 May 2025
PhoenixBio is excited to be sponsoring a booth and attending the International Society for Cell & Gene Therapy (ISCT 2025) in person in New Orleans, USA from May 7th - 10th, 2025. Meet with our team at Booth #223 to learn more about PhoenixBio's capabilities and how we can help you improve lives through safe and effective cell and gene therapies.
1 May 2025
PhoenixBio is excited to be sponsoring a booth and attending the EASL Congress 2025 in person in Amsterdam, the Netherlands from May 7th - 10th, 2025. Meet with our team at Booth #BS24 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.
19 December 2024
The rapid growth of RNA therapeutics, including siRNA and mRNA, is transforming the pharmaceutical and medical landscape, offering unprecedented potential for treating diseases ranging from viral infections to metabolic disorders. Despite this promise, translating these groundbreaking treatments from the lab to the clinic is fraught with challenges.
9 December 2024
Globally, around 250 million people are infected with hepatitis B virus (HBV) and more than 1 million more are estimated to become infected yearly. Researching the HBV viral life cycle and identifying potential novel therapeutics is challenging as only human and chimpanzee hepatocytes are permissive to HBV. However, due to the cost and ethical restrictions, alternative models are being explored. In vivo, rodent models including humanized liver chimeric mice (for example PXB-mice) and the AAV-HBV mouse model are being utilized. While these models are useful, each has their own pitfalls.
17 November 2024
The 75th Liver Meeting organized by the American Association for Liver Disease (AASLD) is being held from November 15th to November 19th, 2024 at the San Diego Convention Center. PhoenixBio is excited to be sponsoring a booth and attending the The Liver Meeting in person in San Diego, California. Meet with our team at Booth #1831 to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s technologies.
21 October 2024
Exciting Innovations Await at the 31st Annual Congress of the European Society of Gene and Cell Therapy. We are thrilled to announce that our company will be attending the 31st Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) in Rome, Italy from October 22nd-25th, 2024. PhoenixBio is excited to be sponsoring a booth and attending the the annual meeting to get the latest updates in the fast moving field of gene and cell therapy! Meet with our team at Booth #B18 to learn more about PhoenixBio's capabilities and how our humanized liver mouse model and fresh human hepatocytes provide an unparalleled translational platform to advance your studies.
10 October 2024
Join us at Delta Cure 2024 in Milan! We’re excited to announce that PhoenixBio will be attending the 3rd Edition of Delta Cure International Meeting in the beautiful city of Milan, Italy on October 11th to October 12th, 2024! This premier event is a fantastic opportunity for pharmaceutical professionals and innovators to gather and explore the latest advancements in viral hepatitis.
